ICMR initiates human clinical trials for improved Kyasanur Forest Disease vaccine

ICMR initiates human clinical trials for improved Kyasanur Forest Disease vaccine

The vaccine has been successfully developed, and animal challenge and toxicity studies have been completed

Leave a Reply

Your email address will not be published. Required fields are marked *